210 results
Page 2 of 11
8-K
EX-10.1
6w25cekq4nifheinhige
25 May 21
Entry into a Material Definitive Agreement
9:04am
8-K
EX-99.1
5t1 iet4gybv62
13 May 21
Heron Therapeutics Announces U.S. FDA Approval of ZYNRELEF™ (HTX-011) for the Management of Postoperative Pain for up to 72 Hours
8:25am
8-K
EX-99.2
swv5ad4l5 xa1e4ovbt
11 Jan 21
Heron Therapeutics Highlights Progress in Pain Management and CINV Franchises and Announces New Development Program
8:40am
8-K
EX-99.1
036ylk7y
2 Oct 19
Heron Announces Positive Topline Results from Phase 3b Clinical Study of HTX-011 in Total Knee Arthroplasty
7:57am
8-K
EX-99.1
ug7th4vm7gqup
20 Aug 19
Heron Therapeutics Announces Publication of Results from EPOCH 2, a Phase 3 Study of HTX-011 in Patients Undergoing Hernia Repair Surgery
8:35am
S-8
EX-99.2
dnip21rvjok 6ixzg
5 Aug 19
Registration of securities for employees
4:53pm